Liu, X., Pan, L., Jia, Y., Wu, D., Xiong, Q., Wang, Y., & Zhu, Y. (2024). Retraction notice to "A novel compound DSC suppresses lipopolysaccharide-induced inflammatory responses by inhibition of Akt/NF-κB signalling in macrophages" [Eur. J. Pharmacol. 708/1–3 (2013) 8–13]. European Journal of Pharmacology, 983, N.PAG. https://doi.org/10.1016/j.ejphar.2024.176993
Chicago Style (17th ed.) CitationLiu, Xin-Hua, Li-Long Pan, Yao-Ling Jia, Dan Wu, Qing-Hui Xiong, Yang Wang, and Yi-Zhun Zhu. "Retraction Notice to "A Novel Compound DSC Suppresses Lipopolysaccharide-induced Inflammatory Responses by Inhibition of Akt/NF-κB Signalling in Macrophages" [Eur. J. Pharmacol. 708/1–3 (2013) 8–13]." European Journal of Pharmacology 983 (2024): N.PAG. https://doi.org/10.1016/j.ejphar.2024.176993.
MLA (9th ed.) CitationLiu, Xin-Hua, et al. "Retraction Notice to "A Novel Compound DSC Suppresses Lipopolysaccharide-induced Inflammatory Responses by Inhibition of Akt/NF-κB Signalling in Macrophages" [Eur. J. Pharmacol. 708/1–3 (2013) 8–13]." European Journal of Pharmacology, vol. 983, 2024, p. N.PAG, https://doi.org/10.1016/j.ejphar.2024.176993.